drugset / Trial / NCT05824832

Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery

NCT05824832

Phase 4 Recruiting 120 enrolled Loyola University
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to learn if there is a difference in morphine requirements in patients after upper extremity surgeries including shoulder arthroscopy. The main question it aims to answer is whether there is a difference between Interscalene brachial plexus blocks with the addition of buprenorphine, dexamethasone, and clonidine and the same block without the adjuvant.

Timeline

Start
2023-02-28
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 0.3 mg Other
Subject Clonidine Other / unclassified 100 ug Other
Subject Dexamethasone Small molecule 4 mg Other
Background Bupivacaine Other / unclassified 0.5 % Other
Background Bupivacaine Other / unclassified 30 ml Other

Indications